The Beauty Health Company (SKIN)
The Beauty Health Company at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
The Beauty Health Company (SKIN) is a Household & Personal Products company based in US with a market capitalization of $100.1M. Revenue declined 10.0% year-over-year and the company generated $37.2M in free cash flow. This page tracks SKIN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 769 employees · IPO Nov 24, 2020
Valuation
Valuation & price
$0.64 · as of May 17, 2026 · -75.5% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
1.64
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$100.1M
Market cap
-10.0%
Revenue growth (YoY)
65.3%
Gross margin
$37.2M
Free cash flow (USD)
$146M
Net debt
2.1%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Consumer Defensive
Sector
Trajectory
Long-term trends
Revenue by year
2018 → 2025
Free cash flow by year
2018 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 7, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventSecurities Class Action SettlementJun 22, 2026Filing
- 8-K eventAnnual Meeting ResultsJun 16, 2026Filing
- 8-K eventSeverance AgreementMay 21, 2026Filing
- 8-K eventDelisting NoticeMay 12, 2026Filing
- 8-K eventEarnings ReleaseMay 7, 2026Filing
- Quarterly report10-Q FiledMay 7, 2026Filing
- 8-K eventCRO DepartureMay 6, 2026Filing
- 8-K eventBylaws AmendedApr 22, 2026Filing
Questions
Frequently asked questions
What is The Beauty Health Company's market cap?
The Beauty Health Company (SKIN) has a market capitalization of $100.1M.
What is SKIN's P/E ratio?
A meaningful P/E ratio is not available for SKIN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is SKIN's price-to-book (P/B) ratio?
SKIN trades at 1.64 times book value per share.
Are insiders buying SKIN stock?
SEC Form 4 filings show no open-market insider buys at The Beauty Health Company in the last 90 days (0 sells).
Same arena
Related companies in Household & Personal Products
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.